#39 - Dr. Joseph Barsuglia: Ibogaine, 5-MeO-DMT, and the Future of Trauma Healing

Dr. Joseph Barsuglia is a clinical and research psychologist, student and initiate of Bwiti, former Christian pastor, and an advisor in psychedelic medicine and alternative healthcare. A co-investigator in the MAPS phase 2 MDMA trials for post-traumatic stress disorder, Dr. Barsuglia has also presented novel observational research on the use of ibogaine and 5-MeO-DMT, and developed guidelines for their administration. Along with his partner and co-founder, Tricia Eastman (a previous Ibogaine Uncovered guest), he has co-led psychedelic retreats through Psychedelic Journeys since 2015. Beond co-founder Talia Eisenberg is a guest co-host on the show.

What We Discuss

• How Dr. Barsuglia first came to know iboga

• What makes iboga such an effective tool for healing trauma

• The unique therapeutic benefits of working with ibogaine and 5-MeO-DMT

• The biggest challenges affecting practitioners offering treatment with psychedelics

• The commonalities and differences between what Indigenous wisdom says and a modern medical approach to psychedelics

• Reconciling Dr. Barsuglia’s Bwiti present with his Christian past

• How Dr. Barsuglia’s spiritual work complements his psychology practice

Why It’s Important

From his work as a Christian pastor to becoming a Bwiti initiate and leader in psychedelic research, Dr. Barsuglia brings a unique blend of clinical expertise and deep spiritual insight to the podcast. He offers a rare perspective on how psychedelics like ibogaine and 5-MeO-DMT can address trauma in ways modern medicine is only beginning to understand, while his journey highlights the potential for integrating spiritual beliefs with therapeutic practice, making this conversation especially meaningful for those exploring the intersection of modern psychology, spirituality, and Bwiti wisdom.

Relevant Links

• Dr. Joseph Barsuglia’s website
• Psychedelic Journeys
• Dr. Barsuglia’s Observational Research
• Dr. Barsuglia’s Peer-Reviewed Work
• Dr. Barsuglia’s Blog
• Dr. Barsuglia on LinkedIn